Hematopoietic Stem Cell Mobilization
"Hematopoietic Stem Cell Mobilization" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The release of stem cells from the bone marrow into the peripheral blood circulation for the purpose of leukapheresis, prior to stem cell transplantation. Hematopoietic growth factors or chemotherapeutic agents often are used to stimulate the mobilization.
| Descriptor ID |
D019650
|
| MeSH Number(s) |
E02.095.410
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hematopoietic Stem Cell Mobilization".
Below are MeSH descriptors whose meaning is more specific than "Hematopoietic Stem Cell Mobilization".
This graph shows the total number of publications written about "Hematopoietic Stem Cell Mobilization" by people in this website by year, and whether "Hematopoietic Stem Cell Mobilization" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 14 | 2 | 16 |
| 2018 | 5 | 1 | 6 |
| 2019 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Hematopoietic Stem Cell Mobilization" by people in Profiles.
-
Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients. Leuk Lymphoma. 2021 12; 62(12):3023-3026.
-
Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma. Transfus Apher Sci. 2021 Oct; 60(5):103197.
-
Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation. Transplant Cell Ther. 2021 03; 27(3):270.e1-270.e6.
-
Predictive factors for stem cell mobilization failure in multiple myeloma patients: A single center experience. Transfus Apher Sci. 2020 Feb; 59(1):102595.
-
High-dose therapy and autologous transplantation for POEMS Syndrome: effective, but how to optimise? Br J Haematol. 2019 09; 186(6):e178-e181.
-
Gender, cholinesterase, platelet count and red cell count are main predictors of peripheral blood stem cell mobilization in healthy donors. Vox Sang. 2019 Apr; 114(3):275-282.
-
Influenza A Infection and Stem Cell Mobilization. Turk J Haematol. 2018 May 25; 35(2):139-140.
-
Comparison of time to engraftment between autologous patients receiving washed versus non-washed cryopreserved peripheral blood stem cell products. Leuk Lymphoma. 2018 12; 59(12):2829-2835.
-
Lenograstim 5 µg/kg is not superior to biosimilar filgrastim 10 µg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study. Transfusion. 2018 05; 58(5):1143-1148.
-
Stem cell mobilization kinetics in elderly patients with multiple myeloma. Transfus Apher Sci. 2018 Apr; 57(2):204-207.